Cargando…
Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen: Implications for Tumor Immunotherapy
The human tyrosinase-derived peptide YMDGTMSQV is presented on the surface of human histocompatibility leukocyte antigen (HLA)-A*0201(+) melanomas and has been suggested to be a tumor antigen despite the fact that tyrosinase is also expressed in melanocytes. To gain information about immunoreactivit...
Autores principales: | Colella, Teresa A., Bullock, Timothy N.J., Russell, Liane B., Mullins, David W., Overwijk, Willem W., Luckey, Chance John, Pierce, Richard A., Restifo, Nicholas P., Engelhard, Victor H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193167/ https://www.ncbi.nlm.nih.gov/pubmed/10748239 |
Ejemplares similares
-
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
por: Overwijk, Willem W, et al.
Publicado: (2013) -
The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol
por: Mosse, Claudio A., et al.
Publicado: (1998) -
Human homologue of murine T200 glycoprotein
Publicado: (1980) -
High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
por: de Vries, T. J., et al.
Publicado: (1998) -
gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand
por: Overwijk, Willem W., et al.
Publicado: (1998)